Technology Licensing

Chinese device makers reflect on a landmark year in FRAND

Leaders from TCL, ZTE and Midea discuss a global litigation landscape that has been changed completely over the past year at IPBC Shenzhen

Chinese device makers reflect on a landmark year in FRAND
The EU has the chance to seize global patent leadership
28 Nov 2020

The EU has the chance to seize global patent leadership

Europe has never been in a better position to set rules the rest of the world must follow

More hold-out on the cards after Dusseldorf court calls in CJEU on SEP licensing
26 Nov 2020

More hold-out on the cards after Dusseldorf court calls in CJEU on SEP licensing

Judges referral of a series of questions on supply chain licensing, FRAND and willing licensee issues have potential to delay dealmaking, not only in Germany but across the EU

Latest

View all
23 Nov 2020

Seven steps to monetising your patent assets

The optimal strategic process to get any rising start-up from initial filings through to licensing income Read more

20 Nov 2020

European Commission set to deliver SEP bombshell

Draft communication suggests intervention in the auto sector to find “effective licensing solutions” and holds out prospect of regulatory reform Read more

17 Nov 2020

Data is the new frontier in healthcare IP licensing, says award-winning TTO

IAM speaks to the tech transfer office of Oregon Health & Science University about the keys to success in university-industry deal-making Read more

16 Nov 2020

Sony court filing highlights challenges for Xperi after Comcast settlement

Japanese company moves for declaratory judgement after licensing discussions break down; claims it sees no reason to do a deal Read more

News

View all
16 Nov 2020

Moderna's covid vaccine is promising news, but IP issues may mean the financial windfall it enjoys are limited

A major PTAB defeat and uncertainties around US government funding cast a royalties shadow over the company's ability to monetise the breakthrough Read more

9 Nov 2020

Pfizer’s covid vaccine found 90% effective, but raises IP questions

Company CEO proclaims “a great day for science and humanity”, but there are patent, know-how and data uncertainties to overcome Read more

6 Nov 2020

Budget pressures accelerate Japan Inc’s IP strategy re-think

Leading lights from Canon, Hitachi and NTT among those who will discuss the way forward at virtual IPBC Japan conference Read more

12 Oct 2020

What world class IP management looks like

On top of high-quality, day-to-day performance in areas such as prosecution, litigation and licensing, there are three essential elements an in-house function requires to be part of the elite Read more

Analysis

View all
10 Nov 2020

Comcast settlement will deliver Xperi extra $50 million in annual royalties, company forecasts

Pair bring an end to long-running and often bitter litigation with a 15-year licence agreement Read more

10 Nov 2020

There has never been a better time to sell or buy drug royalties, says industry veteran

IAM speaks to leading deal-maker David MacNaughtan about his new fund and the growth of this form of life sciences IP monetisation Read more

10 Nov 2020

Big Tech is on notice in China, too

New rules for the internet sector call out long-standing business practices and look at data, technology and IP ownership Read more

9 Nov 2020

Former Nokia Technologies head replaced as CEO of NPE Immersion

Ramzi Haidamus' exit comes despite haptics technology leader eyeing opportunities in gaming from upcoming launch of latest Playstation Read more

Insights

View all
8 Jun 2020

From French fancy to global community – celebrating 100 issues of IAM 

Founder and editor in chief Joff Wild looks back on 17 years of IAM Read more

30 Jan 2019

Apple v Qualcomm is the global patent fight for our times

Why Qualcomm’s winning of an injunction in China against Apple is another sign that the patent market is drifting inexorably eastwards. With the country’s answer to the Court of Appeals for the Federal Circuit opening at the start of this year, rights holders have even more reason to turn to Chinese courts. Read more

30 Nov 2018

After years of setting the patent agenda Silicon Valley is now playing defence

The USPTO director’s explicit rejection of the ‘troll’ narrative and the departure of key Congressional backers mean that big technology companies find themselves in the unusual position of not being in control of the US IP policy-making narrative. Read more

Find an expert